Program Schedule

PW2
Vincent T. Andriole ID Board Review Course $

Tuesday, October 7, 2014: 8:00 AM-5:00 PM
Room: The Pennsylvania Convention Center: 120-ABC

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss and apply updated information on diagnosis and treatment of sexually transmitted diseases
  • assess and apply current trends in vital hepatitis diagnosis and treatment
  • assess and apply current trends in HIV care
  • evaluate and recognize skin manifestations of systemic infections
  • discuss current information on diagnosing and treating fungal infections
  • assess and apply current trends in the diagnosis and treatment of transplant-associated infections
  • discuss common mechanisms of antibiotic resistance and effective components of antimicrobial stewardship programs
  • assess and apply components of effective infection control programs
  • discuss and apply updated information on diagnosis and treatment of bone and joint infections
  • discuss the most common non-infectious causes of fever
  • summarize the most current diseases of travelers and apply updates to patient care
  • discuss the causes and treatment modalities of zoonotic infections

Target Audience: Members-in-training, Infectious diseases physicians

Tracks: Pediatric ID, Investigative ID, HIV-STD-TB, Global ID, Epidemiology and Infection Control, Adult ID

Pre-Meeting Workshop Moderators:  Patty Wright, MD, Vanderbilt University and Richard Whitley, MD, FIDSA, University of Alabama at Birmingham

Presentations:
8:00 AM
W13
Introductory Remarks
Patty Wright, MD
8:15 AM
W14
Sexually Transmitted Diseases
Khalil G. Ghanem, MD, PhD
9:25 AM
W16
Bone and Joint Infections
Elie F. Berbari, MD
10:00 AM
W17
Non-Infectious Causes of Fever
Bennett Lorber, MD, DSc (hon), FIDSA, MACP
10:35 AM
10:50 AM
W18
Fungal Infection Update
Peter Pappas, MD
11:25 AM
W19
Transplant Infections
Robin Avery, MD
12:00 PM
1:35 PM
W21
Infection Control
Kerri Thom, MD, MS
2:10 PM
2:25 PM
W22
HIV Update
Roy M. Gulick, MD, MPH, FIDSA
Presentations
  • Gulick_ART 2014.pdf (296.4 kB)
  • 3:00 PM
    W23
    Viral Hepatitis
    Susanna Naggie, MD
    Presentations
  • Naggie_The ABCs of Viral Hepatitis.pdf (650.1 kB)
  • 3:35 PM
    W24
    Travel Medicine
    Thomas A. Moore, MD, FIDSA
    Presentations
  • Moore_Andriole 2014 handout.pdf (80.2 kB)
  • 4:10 PM
    W25
    Zoonoses
    Joseph Vinetz, MD, FIDSA

    CME Credits: Maximum of 7.5 hours of AMA PRA Category 1 CreditTM

    ACPE Credits: No CPE credit is offered for this session.

    ACPE Number:

    Disclosures:

    P. Wright, None

    K. G. Ghanem, None

    S. Naggie, Abbvie: Consultant, revenues from these activities are paid to the University. None of it is taken for personal income.
    Achillion: Consultant, revenues from these activities are paid to the University. None of it is taken for personal income.
    BMS: Consultant, revenues from these activities are paid to the University. None of it is taken for personal income.
    Gillead: Consultant, revenues from these activities are paid to the University. None of it is taken for personal income.
    Vertex: Consultant, revenues from these activities are paid to the University. None of it is taken for personal income.
    IAS-USA: Collaborator and Member, Educational Activities or Lectures for this Company Generates Revenue for Duke
    IDSA: Collaborator and Member, Educational Activities or Lectures for this Company Generates Revenue for Duke

    R. M. Gulick, None

    S. Long, None

    P. Pappas, Merck: Grant Investigator and Scientific Advisor, Consulting fee and Grant recipient
    Astellas: Grant Investigator, Grant recipient
    Gilead: Grant Investigator and Scientific Advisor, Consulting fee and Grant recipient
    T2 Biosystems: Grant Investigator and Scientific Advisor, Consulting fee and Grant recipient
    Scynexis: Grant Investigator and Scientific Advisor, Consulting fee and Grant recipient
    Viamet: Scientific Advisor, Consulting fee

    R. Avery, Viropharma/Shire: Investigator, Research support
    Astellas: Investigator, Research support
    Chimerix: Investigator, Research support
    Merck: Investigator, Research support

    L. Abbo, None

    K. Thom, None

    E. F. Berbari, None

    B. Lorber, None

    T. A. Moore, None

    J. Vinetz, None

    P. Wright, None

    See more of: Premeeting Session

    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, idweek.org. All Rights Reserved.

    Follow IDWeek